Background Metabolic associated fatty liver disease (MAFLD) is a progressive chronic liver
disease, yet there is still a lack of effective pharmacological therapies at present …

Nonalcoholic fatty liver disease (NAFLD) has become one of the most prominent causes of
chronic liver diseases and malignancies. However, few therapy has been approved. Radix …

Ethnopharmacological relevance Hyperlipidemia is the systemic manifestation of abnormal
lipid metabolism, characterized by elevated circulating levels of cholesterol and triglyceride …

Abstract Background Schisandrin B (Sch B), which inhibits hepatic steatosis caused by non-
alcoholic fatty liver disease (NAFLD), is one of the most active dibenzocyclooctadienes …

Nonalcoholic fatty liver disease (NAFLD) is considered to be a hepatic manifestation of the
metabolic syndrome, and the incidence of NAFLD is increasing rapidly. However …

Liver disorders are a major health concern. Saikosaponin-d (SSd) is an effective active
ingredient extracted from Bupleurum falcatum, a traditional Chinese medicinal plant, with …

Background Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease worldwide. Shenge Formula (SGF) is a traditional Chinese medicine that has been …

Background Non-alcoholic steatohepatitis (NASH) represents the more severe end of
hepatic steatosis and is associated with progressive liver disease. Calycosin, derived from …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease and is characterized by excessive hepatic lipid accumulation. Many studies have …

Non-alcoholic fatty liver disease (NAFLD) has become one of the main chronic liver
diseases worldwide. Protopanaxadiol (PPD), an active compound derived from …